1.
Biotechnol Healthc
; 9(3): 22-6, 2012.
Article
in English
| MEDLINE
| ID: mdl-23091431
ABSTRACT
Autonomy, innovation, and drug access may be at stake along with personalized medicine. Can all stakeholders be satisfied and should cost be a factor?